AstraZeneca PLC
$120.49
24H
Market Cap
Volume
Supply
Price Chart
About AstraZeneca PLC - AZN.L
AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in several therapeutic areas, including oncology, cardiovascular, gastrointestinal, respiratory, and immunology. The company has a portfolio of products for major disease areas and conducts research and development across the globe.
What are AstraZeneca PLC's core values and mission statement?
AstraZeneca PLC's mission statement focuses on delivering life-changing medicines, and they commit to 'following the science' and putting patients first. The company's core values emphasize the importance of trust, transparency, integrity, and respect for their people and the broader communities in which they operate.
Who founded AstraZeneca PLC and when?
AstraZeneca PLC was formed through the merger of the Swedish company Astra AB and the British company Zeneca Group PLC in 1999.
Who leads AstraZeneca PLC?
As of the last update I have, Pascal Soriot is the Chief Executive Officer of AstraZeneca PLC.
Where is AstraZeneca PLC located, and what is its base country?
AstraZeneca PLC is headquartered in Cambridge, United Kingdom, which is its base country.
On which exchanges is AstraZeneca PLC traded?
AstraZeneca PLC is primarily listed on the London Stock Exchange (LSE) under the symbol "AZN" and also has a secondary listing on the Nasdaq Stock Market in the United States under the ticker "AZN".
Historical data
AstraZeneca PLC (AZN) Price Live Data
The live price of AstraZeneca PLC (AZN) is $120.49, with a trading volume of 470,212 in the last 24 hours. Wrapstocks updates the AZN price in real-time. AstraZeneca PLC is up 0.7% in the last 24 hours. The company has a live market cap of $1,867,982,475.07 and a supply of 15,503,000 AZN stocks.
AstraZeneca PLC (AZN) is traded on London Stock Exchange, and currently, the market is open; trading will be paused in 37 minutes.
